Individualizing Analgesic Regimens: Strategies to Reduce Abuse and Diversion

Effective Dates
April 2008 through April 30, 2009 - Extend to October 31, 2009

Intended Audience
Physicians and other health professionals who treat patients with chronic pain

Method of Participation
Read/listen to the Highlights Report, complete the Activity Evaluation and Request for Credit Form, and receive your certificate immediately. This activity is provided free of charge to participants.

Accreditation
Veritas Institute for Medical Education, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation of Credit
Veritas Institute for Medical Education, Inc. designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit^TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Sponsorship and Support
Sponsored by Veritas Institute for Medical Education, Inc.

Supported by an educational grant from PriCara, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., administered by Ortho-McNeil Janssen Scientific Affairs, LLC. 

Learning Objectives

• You will be able to select screening instruments to assess patients with pain for risk of opioid misuse and institute monitoring strategies based on this risk.

• You will be able to specify nonpharmacologic interventions for pain treatment when opioids are not indicated and/or as complements to indicated opioid therapy.

• You will be able to evaluate the efficacy and risk potential of current and emerging opioid analgesic agents for patients with chronic pain.

• You will be able to design and implement a legal foundation for your pain practice.

Financial Disclosure Summary
In accordance with the ACCME?s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control. Disclosures are as follows:

Jennifer E. Bolen, JD: Advanced Bionics Corporation (coordinator for CME grant money), Aegis Sciences Corporation (speakers bureau), AIT Laboratories (coordinator for CME grant money), Alpharma Inc (coordinator for CME grant money), Ameritox (coordinator for CME grant money, speakers bureau), American Neurotology Society (coordinator for CME grant money), Cephalon Inc (coordinator for CME grant money, speakers bureau), Endo Pharmaceuticals (coordinator for CME grant money), King Pharmaceuticals Inc (consultant, coordinator for CME grant money, speakers bureau), McMahon Group (author), Medtronic Inc (coordinator for CME grant money, speakers bureau), PriCara (speakers bureau).

Matthew J. Loscalzo, MSW, has nothing to disclose.

Bill McCarberg, MD: Abbott Laboratories (speakers bureau), Alpharma Inc (speakers bureau), Cephalon Inc (speakers bureau), Endo Pharmaceuticals (speakers bureau), Merck & Co, Inc (speakers bureau), Eli Lilly and Company (speakers bureau), Mylan Inc (speakers bureau), Pfizer Inc (speakers bureau), PriCara (speakers bureau), Purdue Pharma LP (speakers bureau).

Steven D. Passik, PhD: Cephalon Inc (speakers bureau, consultant, grant/research support), King Pharmaceuticals Inc (speakers bureau, consultant), Ligand Pharmaceuticals (speakers bureau, consultant, grant/research support), Eli Lilly and Company (speakers bureau, consultant), PriCara (speakers bureau, consultant).

Thomas N. Watson, DPT, MEd, has nothing to disclose.

The staff of Veritas Institute for Medical Education, Inc. has nothing to disclose.

Off-Label/Investigational Uses of Drugs
Participants are advised that this CME activity will contain references to the unlabeled/unapproved/investigational uses of drugs to treat patients experiencing chronic nonmalignant pain.

Disclaimer
The opinions expressed in this activity are those of the faculty and do not necessarily reflect those of Veritas Institute for Medical Education, Inc. or PriCara, Division of Ortho-McNeil Janssen Pharmaceuticals, Inc., administered by Ortho-McNeil Janssen Scientific Affairs, LLC. Please consult the appropriate package insert for full prescribing information on all drug therapies discussed.

Distinguished Faculty

Chair
Steven D. Passik, PhD
Associate Attending Psychologist
Memorial Sloan-Kettering Cancer Center
Associate Professor of Psychiatry
Weill College of Cornell Medical Center
New York, New York

 

Faculty
Jennifer E. Bolen, JD
Founder
The Legal Side of Pain^®
The J. Bolen Group, LLC
Lenoir City, Tennessee     

Matthew J. Loscalzo, MSW
Administrative Director
Supportive Care Medicine
City of Hope
Duarte, California

Bill McCarberg, MD
Family Medicine
Escondido, California

Thomas N. Watson, DPT, MEd
Doctor of Physical Therapy
Peak Performance Physical Therapy
Redmond, Oregon

Copyright © 2008 Veritas Institute for Medical Education, Inc. All rights reserved.
Terms and conditions / Privacy statement

 

 

Click here to complete the preactivity assessment and access the Highlights Report and Podcast